Ads
related to: hepatitis b
Search results
Small Business - Salisbury Post | Salisbury Post
The Salisbury Post· 3 days agoAt the end of treatment, 33.3% of patients receiving imdusiran for 48 weeks, interferon (IFN) for 24 weeks and ongoing nucleoside analogue (NA) therapy achieved undetectable levels of HBsAg that were maintained in 100% of these patients 24 weeks
The Hunt for Virus Treatments Continues Post Covid-19
Digital Journal· 22 hours agoVancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - June 7, 2024) - Investorideas.com, a go-to investing platform, releases the second of a two-part series looking at news and ...
Vir Biotechnology (VIR) Up on Positive Data From HDV Study
Zacks· 2 days agoVir Biotechnology (VIR) rises on upbeat data from its phase II study evaluating tobevibart and...
Is It Safe to Breastfeed If There Is Blood In Breast Milk?
Parents via Yahoo News· 4 days agoUnderstand what conditions might cause blood to appear in breastmilk, and if it's safe to continue...
LGBTQ+ population faces greater cancer risks. Also faces barriers to care, studies show.
USA TODAY via Yahoo News· 5 days agoCorrection: This story was updated to reflect that hepatitis B vaccinations were higher among LGBTQ+ people than heterosexual adults. LGBTQ+ people are ...
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks via Yahoo Finance· 2 days agoTobevibart is an investigational subcutaneously administered antibody designed to inhibit entry of ...
GSK acquires oligonucleotide drug startup Elsie
BioPharma Dive via Yahoo Finance· 2 days agoGSK’s efforts around oligonucleotides also coincide with the company’s pivot away from cell therapies. One of its most advanced candidates comes from...
Live from ASCO 2024 | Ascentage Pharma Releases Updated Data of FAK/ALK/ROS1 Inhibitor APG-2449 in...
Benzinga· 6 days agoSUZHOU, China, and ROCKVILLE, Md., June 1, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic
Aligos Therapeutics Presents Positive Data at the EASL Congress 2024 - Aligos Therapeutics...
Benzinga· 3 days agoSOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (NASDAQ:ALGS, "Aligos")), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet
"Flattered and Humbled": Two NASA astronauts inducted into Hall of Fame under Atlantis
Florida Today via Yahoo News· 7 days agoCenter Visitor Complex press release, Hilmers currently serves as the Chief Medical Officer for Dr....
